NCT04344496View on ClinicalTrials.gov

East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

October 31, 2025

Study Completion Date

July 31, 2028

Conditions
Breast Cancer
Interventions
OTHER

PAM50

PAM50 results is as one of the references for the physicians and the participants to choose adjuvant treatments.

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER